Diabetes Tech Update
Jake discusses the delayed FDA approval for a diabetes product due to a unique user-requested feature. The feature allows users to silence alerts for up to 6 hours, addressing a common user need for more control over glucose alerts.In this clip
From this podcast
Juicebox Podcast: Type 1 Diabetes
#806 Dexcom G7 Approved By FDA (with Dexcom COO Jake Leach)
Related Questions